Shopping Cart
- Remove All
- Your shopping cart is currently empty
MPT0B392 is an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,270 | 6-8 weeks | |
50 mg | $1,650 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | MPT0B392 is an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation. |
In vitro | MPT0B392 induces apoptosis in HL60 cancer cells[1]. MPT0B392 (0.1 μM for 6-48 hours; 0.01-0.1 μM for 24 and 48 hours) triggers cells arrest in the G2/M phase, followed by accumulation in subG1 phase in a concentration and time-dependent manner[1]. MPT0B392 (0.1 μM; 48 hours) increases the phosphorylation of Bcl-2, Mcl-1S and decreases in Mcl-1L[1]. |
In vivo | MPT0B392 shows relative potent anti-leukemia activity in a vivo xenograft model[1]. |
Molecular Weight | 404.44 |
Formula | C19H20N2O6S |
Cas No. | 1346169-92-3 |
Relative Density. | 1.332 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.